JOVIC, Gordana
 Distribuzione geografica
Continente #
NA - Nord America 1.751
EU - Europa 1.032
AS - Asia 258
AF - Africa 15
SA - Sud America 5
OC - Oceania 2
Totale 3.063
Nazione #
US - Stati Uniti d'America 1.737
GB - Regno Unito 255
SE - Svezia 191
IE - Irlanda 179
IT - Italia 159
CN - Cina 93
DE - Germania 91
UA - Ucraina 54
HK - Hong Kong 47
SG - Singapore 35
FI - Finlandia 34
TR - Turchia 32
BG - Bulgaria 19
LT - Lituania 19
IN - India 15
VN - Vietnam 12
CA - Canada 10
RU - Federazione Russa 10
ET - Etiopia 7
ID - Indonesia 6
FR - Francia 5
KE - Kenya 4
MY - Malesia 4
ES - Italia 3
IQ - Iraq 3
IR - Iran 3
MX - Messico 3
NL - Olanda 3
TW - Taiwan 3
AU - Australia 2
BE - Belgio 2
BO - Bolivia 2
EG - Egitto 2
GR - Grecia 2
JP - Giappone 2
AE - Emirati Arabi Uniti 1
BR - Brasile 1
BZ - Belize 1
CL - Cile 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
HU - Ungheria 1
LB - Libano 1
MA - Marocco 1
ME - Montenegro 1
NG - Nigeria 1
NO - Norvegia 1
PT - Portogallo 1
RO - Romania 1
SA - Arabia Saudita 1
Totale 3.063
Città #
Fairfield 219
Southend 201
Chandler 182
Dublin 179
Woodbridge 155
Ashburn 137
Houston 132
Dearborn 118
Nyköping 109
Jacksonville 100
Seattle 85
Cambridge 81
Wilmington 69
Ann Arbor 68
New York 48
Hong Kong 42
Beijing 40
Izmir 24
Modena 24
San Diego 24
Singapore 23
Princeton 22
Helsinki 20
Eugene 19
Sofia 19
Milan 16
Dong Ket 12
Des Moines 11
Lansdale 11
Shanghai 10
London 9
Rome 9
Palermo 8
Bremen 7
Jakarta 6
Stockholm 6
Nanjing 5
Phoenix 5
Tulsa 5
Falls Church 4
Gallarate 4
Kunming 4
Norwalk 4
Ottawa 4
Redwood City 4
San Mateo 4
Augusta 3
Bangalore 3
Boardman 3
Burlington 3
Chiswick 3
Cremona 3
Fremont 3
Hounslow 3
Madrid 3
Mexicali 3
Munich 3
Nairobi 3
Naples 3
Padova 3
Taipei 3
Vicenza 3
Yuen Long San Hui 3
Amsterdam 2
Athens 2
Bari 2
Berlin 2
Cortona 2
Dallas 2
Foligno 2
Grafing 2
Guangzhou 2
Hefei 2
La Paz 2
Leawood 2
Mumbai 2
Nanchang 2
Pesaro 2
San Polo in Chianti 2
Turin 2
Venice 2
Verona 2
Washington 2
Acton 1
Agrigento 1
Albuquerque 1
Ankara 1
Auburn Hills 1
Beit Meri 1
Belize City 1
Benevento 1
Bologna 1
Bremerhaven 1
Bridgnorth 1
Brno 1
Brussels 1
Budrio 1
Buffalo 1
Cagliari 1
Carpiano 1
Totale 2.396
Nome #
Comparison of HER-2 and hormone receptor expression in primary breast cancers and asynchronous paired metastases: impact on patient management 280
Helicobacter pylori infection andchronic immune thrombocytopenic purpura: long-term results of bacteriumeradication and association with bacterium virulence profiles 244
Letrozole Versus Letrozole Plus Lapatinib (GW572016) in Hormone-Sensitive, HER2-Negative Operable Breast Cancer: A Double-Blind, Randomized Phase II Study with Biomarker Evaluation (EGF109077-LAP107692/LETLOB) 239
Phase II, randomized trial of preoperative epirubicin-paclitaxel +/- gefitinib with biomarker evaluation in operable breast cancer. 219
MODULAZIONE DELL’ESPRESSIONE DI BIOMARCATORI E PROGNOSI IN PAZIENTI AFFETTE DA CARCINOMA MAMMARIO OPERABILE SOTTOPOSTE A CHEMIOTERAPIA PREOPERATORIA 196
A prognostic model based on nodal status and Ki-67 predicts the risk of recurrence and death in breast cancer patients with residual disease after preoperative chemotherapy. 191
Prognostic and Predictive Value of Baseline and Posttreatment Molecular Marker Expression in Locally Advanced Rectal Cancer Treated With Neoadjuvant Chemoradiotherapy 176
Middle turbinate preservation versus middle turbinate resection in endoscopic surgical treatment of nasal polyposis 172
CHER LOB Trial: Preoperative chemotherapy plus trastuzumab, lapatinib or both in HER2-positive operable breast cancer--Safety report as per Independent Data Monitoring Committee (IDMC) and preliminary activity data 171
Preoperative chemotherapy plus lapatinib or trastuzumab or both in Her2 positive operable breast cancer. EGF109085-LAP106988/CHERLOB Trial. 170
Prognostic value of Dworak grade of regression (GR) in patients with rectal carcinoma treated with preoperative radiochemotherapy 161
Preliminary safety data of preoperative chemotherapy plus trastuzumab, lapatinib or both in HER2-positive operable breast cancer 141
PROLIFERATION AND APOPTOSIS BEFORE AND AFTER PRIMARY SYSTEMIC THERAPY FOR OPERABLE BREAST CANCER 126
CHER-LOB: PREOPERATIVE CHEMOTHERAPY PLUS TRASTUZUMAB, LAPATINIB OR BOTH IN HER2-POSITIVE OPERABLE BREAST CANCER – PRELIMINARY SAFETY REPORT WITH FOCUS ON CARDIAC TOLERABILITY 118
LET-LOB: preoperative letrozole plus lapatinib or placebo in hormone-receptor positive HER2 negative operable breats cancer. Preliminary report of activity and cardiac tolerability 114
Biomarker expression and survival after primary chemotherapy for breast cancer. 110
COMPARISON OF HER-2 STATUS IN PRIMARY BREAST CANCER AND METASTATIC SITES: RESULTS FROM A SINGLE INSTITUTION ANALYSIS 100
CHEMOTHERAPY-INDUCED MODULATION OF BIOMARKERS EXPRESSION IN PRIMARY BREAST CANCER PATIENTS TREATED WITH PREOPERATIVE CHEMOTHERAPY 85
Final results of a phase II, double blind, placebo controlled, randomized trial of preoperative chemotherapy +/- gefitinib with biomarker evaluation in operable breast cancer 78
Totale 3.091
Categoria #
all - tutte 11.062
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.062


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020535 0 0 13 46 74 117 100 56 58 21 34 16
2020/2021441 51 16 34 35 39 27 58 45 28 36 40 32
2021/2022394 7 52 59 23 10 32 24 13 39 17 75 43
2022/2023679 88 82 32 56 45 59 21 36 215 4 8 33
2023/2024379 18 22 22 29 81 45 23 55 16 9 33 26
2024/202549 28 21 0 0 0 0 0 0 0 0 0 0
Totale 3.091